Long-Term Neurodevelopment After Cooling for Hypoxic-Ischemic Encephalopathy Shows No Clear Winner
Therapeutic hypothermia has become a standard neuroprotective approach for newborns with hypoxic-ischemic encephalopathy (HIE), but the long tail of recovery matters as much as the acute NICU course. In this retrospective cohort, long-term cognitive and developmental testing in children treated with cooling therapy did not separate cleanly between combined hypothermia (CH) and whole-body cooling (WBC). The broader signal was more sobering: children with a history of HIE and cooling therapy performed worse than healthy peers on several measures of cognition and development, even when the two cooling strategies looked broadly similar to each other.
The study followed 50 children diagnosed with HIE and treated in a neonatal intensive care unit between 2015 and 2021. A comparison group of healthy children of similar age provided a reference point for interpretation of later neurodevelopmental testing. The assessment battery was not superficial. Investigators used the Wechsler Intelligence Scale for Children-IV (WISC-IV), the Stroop Test, and the Denver II Developmental Screening Test, giving the analysis a window into overall intellect, executive control, and developmental performance.
One sentence captures the clinical tension in the dataset: the two cooling strategies looked comparable overall, yet neither erased the developmental burden of HIE.
Cognitive Testing Exposes Residual Injury Beyond the NICU
The most clinically meaningful divergence came when the cooling groups were measured against healthy children. The Full Scale IQ was significantly lower in the CH group than in controls, and the cooling-treated children as a whole showed more abnormalities on the Stroop and Denver II tests than the healthy group. In bedside terms, that pattern suggests that therapeutic cooling may reduce acute brain injury without guaranteeing normal later executive function, attention, or developmental milestone attainment.
This is biologically plausible. HIE can trigger diffuse neuronal loss, white matter injury, and delayed disruption of networks that support processing speed and inhibitory control. Cooling can blunt the cascade of excitotoxicity, oxidative stress, and inflammation after perinatal asphyxia, but the intervention cannot reverse all established injury. If brain development is still unfolding during infancy and early childhood, even modest residual damage may surface later as weaker performance on tests that probe planning, cognitive flexibility, and language-linked problem solving.
The Stroop findings fit that framework. Executive function tests are often less forgiving than global developmental screens because they expose subtle deficits in attention and response inhibition that can remain hidden during routine follow-up. A child may appear clinically stable, yet still struggle with the kind of higher-order processing that affects classroom performance, behavior regulation, and later learning.
Combined Hypothermia and Whole-Body Cooling Look Similar, but the Study Was Not Built to Declare Equivalence
No significant difference emerged between CH and WBC in overall outcomes. In practical terms, that leaves clinicians without evidence that one approach produces clearly superior long-term neurodevelopmental results in this cohort. The weak subdomain findings in the CH group deserve attention, though they do not establish a definitive advantage for WBC. Retrospective design, a small sample, and the limits of nonrandomized comparison all constrain how far the signal can be pushed.
The absence of a clear between-treatment difference may reflect a true similarity in biologic effect. Both strategies lower body temperature enough to reduce secondary injury after hypoxia-ischemia, and both likely act through overlapping pathways involving metabolic suppression and stabilization of injured neurons. If the main determinant of long-term outcome is the severity of the original insult, then modest differences between cooling methods may be difficult to detect unless the study is large and tightly controlled.
Healthy Controls Set the Benchmark the Cooling Arms Could Not Reach
The comparison with healthy children is where the study sharpens. Even when the two cooling groups look broadly alike, both remain separated from children without HIE on developmental and cognitive measures. This matters because it reframes therapeutic hypothermia as a treatment that may reduce harm rather than fully normalize neurodevelopmental trajectories.
For families, that distinction can be difficult to absorb after an ICU course that already feels like a victory. For clinicians, it means follow-up cannot end when the infant survives the neonatal period. Children who received cooling for HIE may still need structured surveillance for learning problems, attention deficits, language delay, and motor or behavioral concerns well into childhood.
The data also reinforce a familiar truth in neonatal neurology: a normal discharge exam does not guarantee a normal school-age profile. Developmental testing later in childhood can reveal deficits that were not obvious early on, especially in domains that depend on executive control and integrated cognition.
Follow-Up Needs to Match the Persistence of Brain Injury
The study’s retrospective structure limits causal interpretation, and the small number of children tempers confidence in subgroup findings. Even so, the message is clinically direct. Cooling remains essential therapy for HIE, but long-term surveillance is just as essential because the treatment does not fully erase neurodevelopmental risk.
Future work will need larger prospective cohorts with standardized injury grading, detailed perinatal variables, and longer follow-up into school age and adolescence. Those studies will be better positioned to determine whether one cooling strategy meaningfully outperforms another in specific cognitive domains, or whether the more important driver is the original severity of hypoxic-ischemic injury.
For now, the most defensible conclusion is narrow: CH and WBC did not differ significantly in overall long-term outcomes, yet children with HIE still showed measurable deficits compared with healthy peers, including lower full-scale IQ in the CH group and more abnormalities on executive and developmental testing across the cooling-treated cohort.